Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly
ACUR [NASD]
Acura Pharmaceuticals Inc.
Healthcare | Drug Delivery | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.24 Insider Own1.61% Shs Outstand46.38M Perf Week7.76%
Market Cap109.46M Forward P/E19.67 EPS next Y0.12 Insider Trans-84.03% Shs Float45.84M Perf Month-8.88%
Income-11.55M PEG- EPS next Q- Inst Own77.45% Short Float3.28% Perf Quarter13.46%
Sales0.00M P/S- EPS this Y-194.05% Inst Trans1.79% Short Ratio1.99 Perf Half Y114.55%
Book/sh0.49 P/B4.82 EPS next Y138.70% ROA-38.58% Target Price4.50 Perf Year-13.24%
Cash/sh0.51 P/C4.67 EPS next 5Y- ROE-40.70% 52W Range1.06 - 4.50 Perf YTD6.31%
Dividend- P/FCF- EPS past 5Y58.88% ROI-40.70% 52W High-47.56% Beta0.82
Dividend %- Quick Ratio10.96 Sales past 5Y- Gross Margin- 52W Low122.64% ATR0.22
Employees15 Current Ratio11.13 Sales Q/Q- Oper. Margin- RSI (14)51.99 Volatility7.39% 6.98%
OptionableYes Debt/Eq0.00 EPS Q/Q-84.01% Profit Margin- Rel Volume0.35 Prev Close2.34
ShortableYes LT Debt/Eq0.00 EarningsMay 02 AMC Payout- Avg Volume754.95K Price2.36
Recom2.00 SMA201.51% SMA501.82% SMA20019.01% Volume267,979 Change0.85%
17-May-13 11:04AM  Acura Pharmaceuticals Is Grossly Undervalued And Poised For Rapid Growth at Seeking Alpha +7.31%
16-May-13 02:05PM  3 Companies That Put the "Tech" in "Biotech" at Motley Fool
12-May-13 03:51PM  No Relief in Sight for Pain Investors at Motley Fool
10-May-13 11:35AM  Pain Therapeutics, Durect fall on Remoxy review AP
08-May-13 01:04PM  ACURA PHARMACEUTICALS, INC Financials EDGAR Online Financials
03-May-13 03:10PM  Acura Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha -7.79%
12:09PM  Learn Which Antibody Companies Show Show a Higher Probability of Success; Antibodies Have a Higher Track Record of M&A and More Predictable Toxicology Profile Wall Street Transcript
02-May-13 04:10PM  Acura Pharmaceuticals Announces First Quarter 2013 Financial Results Marketwired
04:10PM  Acura Pharmaceuticals Announces First Quarter 2013 Financial Results Marketwire
09:32AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
07:07AM  Q1 2013 Acura Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
01:15AM  Why Did Pain Therapeutics Increase Over 25%? at Seeking Alpha
27-Apr-13 07:15AM  The Fool Looks Ahead at Motley Fool
22-Apr-13 04:15PM  Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013 Marketwired
04:15PM  Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013 Marketwire
19-Apr-13 07:42PM  Society And The FDA Are Ready For Acura, Are You? at Seeking Alpha +8.71%
18-Apr-13 09:14PM  The Hidden Winner of the FDAs Anti-Generic Decision at Motley Fool -8.33%
08:47PM  The Hidden Winner of the FDAs Anti-Generic Decision at Motley Fool
08:22PM  The Hidden Winner of the FDAs Anti-Generic Decision at Motley Fool
07:58PM  The Hidden Winner of the FDAs Anti-Generic Decision at Motley Fool
05:07PM  4 Healthcare Stock Stories for Thursday Investment Wellness at Wall St. Cheat Sheet
04:50PM  Whoa! What Just Happened to My Stock? at Motley Fool
01:11PM  5 Stocks Under $10 Set to Soar at TheStreet
09:35AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E EDGAR Online
17-Apr-13 07:34PM  The Hidden Winner of the FDAs Anti-Generic Decision at Motley Fool +33.95%
04:32PM  On The Fly: Closing Wrap at theflyonthewall.com
02:07PM  Wednesday Sector Leaders: Drugs, Cigarettes & Tobacco Stocks at Forbes
01:17PM  Acura Pharma rises on FDA OxyContin decision AP
10:13AM  Endo, Acura gain after FDA blocks OxyContin generics at theflyonthewall.com
06:31AM  FDA Upgrades Acura Pharmaceuticals To A Public Health Priority at Seeking Alpha
08-Apr-13 09:54AM  A Look At One Of The Fastest Growing Industries In The Market And How To Benefit at Seeking Alpha
05-Apr-13 03:12PM  4 Healthcare Stock Stories for Weekend Investment Wellness at Wall St. Cheat Sheet
02:32PM  5 Stocks Poised for Breakouts at TheStreet
08:12AM  2 Strategic Partnerships Fueling The Performance Of Acura Pharmaceuticals at Seeking Alpha
04-Apr-13 04:16PM  InPlay: Acura Pharma awarded U.S. patent for abuse deterrent drug formulations Briefing.com
04:15PM  Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations Marketwired
04:15PM  Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations Marketwire
09:51AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online
18-Mar-13 12:06PM  European Exposure Slows Down Large Medical Device Companies; Holding Smaller Names May Result in More Upside When Investing in This Healthcare Segment, According to Expert Equity Analyst Wall Street Transcript
15-Mar-13 12:34PM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online -6.37%
12:01PM  Acura Pharmaceuticals' Universal Shelf Registration Statement Declared Effective Marketwired
12:01PM  Acura Pharmaceuticals' Universal Shelf Registration Statement Declared Effective Marketwire
14-Mar-13 08:20AM  U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous Marketwired
08:20AM  U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous Marketwire
11-Mar-13 04:02PM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03:44PM  A Quick Look At 8 Biotechs Ready To Gain Momentum at Seeking Alpha
08-Mar-13 01:04PM  ACURA PHARMACEUTICALS, INC Financials EDGAR Online Financials +6.97%
07-Mar-13 01:11PM  Why Did My Stock Just Die? at Motley Fool -8.61%
06-Mar-13 07:31AM  Hot Stock Minute: Dow About To Open At Record High Hot Stock Minute -12.17%
05-Mar-13 05:18PM  Sears, Google, Cree are big movers AP +48.29%
04:13PM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03:06PM  Using Evidence to Identify Catalysts for Growth: an Exclusive Wall Street Transcript Interview Names Some of the Top Stock Picks of Becker Capital Management's Expert Portfolio Managers Wall Street Transcript
11:42AM  Acura Pharma jumps on Nexafed pharmacy deal AP
10:47AM  CAPScall of the Week: Zogenix at Motley Fool
09:05AM  Tuesdays movers: Acura, Gilead, Apple at MarketWatch
06:15AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online
06:00AM  Acura Pharmaceuticals Reaches Key Milestone With Entrance Into Chain Drug Store Market Marketwire
04-Mar-13 05:03PM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04:28PM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:18PM  ACURA PHARMACEUTICALS, INC Files SEC form 10-K, Annual Report EDGAR Online
04:15PM  Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2012 Financial Results Marketwire
28-Feb-13 08:36AM  CAPScall of the Week: Acura Pharmaceuticals at Motley Fool
22-Feb-13 10:00AM  Acura Pharmaceuticals to Present at the Cowen Health Care Conference on March 5, 2013 Marketwire
13-Feb-13 09:56AM  3 Stocks to Get on Your Watchlist at Motley Fool
08-Feb-13 12:01PM  Response Genetics' Competitors: Who To Watch, Who To Worry About at Seeking Alpha
07-Feb-13 02:02PM  Four charts to watch at MarketWatch
08:20AM  Mergers and Acquisitions on the Rise in 2013 as Big Pharma Companies Hold Record Amounts of Cash on Hand Marketwire
03-Jan-13 07:00AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +9.48%
20-Dec-12 08:17AM  Acura Pharma submits Investigational NDA theflyonthewall.com
08:15AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online
08:00AM  InPlay: Acura Pharmaceuticals submits investigational new drug application Briefing.com
08:00AM  Acura Pharmaceuticals, Inc. Submits Investigational New Drug Application Marketwire
17-Dec-12 10:08AM  Weekly Biotech Recap: Anticipation, Divergence at Seeking Alpha +5.75%
09:33AM  This Week in Biotech at Motley Fool
08:02AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online
15-Dec-12 11:36AM  Accurate Time for Acura at Motley Fool
14-Dec-12 01:50PM  Is Zogenix A Buy After FDA Panel Says 'No' To Zohydro? at Seeking Alpha
13-Dec-12 07:54PM  Why Acura Is Poised to Pull Back at Motley Fool -11.49%
09:59AM  How to Play Monday's Biggest Market Movers at Motley Fool
11-Dec-12 03:14PM  Midday Nasdaq Rises on Tech Stocks and Fiscal Cliff Optimism at Minyanville +42.45%
10-Dec-12 09:05PM  Learn Why 4 Dow Stocks Fell Today at Motley Fool +71.33%
06:46PM  Acura Investors: Why Shares Popped 70% at Motley Fool
03:40PM  Acura debuts abuse-resistant decongestant Nexafed AP
03:01PM  Acura Pharmaceuticals Launches Meth-Resistant Pseudoephedrine, Nexafed at Forbes
03:01PM  Acura Pharma Launches Meth-Resistant Pseudoephedrine, Nexafed at Forbes
02:04PM  2 Significant Drug Developments Coming Out Of The Biotech Sector at Seeking Alpha
08:04AM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Other Events EDGAR Online
08:00AM  Acura Pharmaceuticals Launches Next Generation Cold Medicine to Aid in the Fight Against Meth Marketwire
05:26AM  Positive Year End Catalysts Makes Acura A Buy at Seeking Alpha
01-Dec-12 08:32AM  Is the Risk Worth the Reward for Biotechs Most Volatile? at Motley Fool
30-Nov-12 08:21AM  Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012 Marketwire -6.15%
08:20AM  Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012 Marketwire
29-Nov-12 11:07PM  WellPoint/Amerigroup Merger Okayed, New Acura Product News: Healthcare Business Recap at Wall St. Cheat Sheet +37.32%
03:18PM  WellPoint/Amerigroup Merger Okayed, New Acura Product News: Healthcare Business Recap at Wall St. Cheat Sheet
27-Nov-12 01:49PM  Q3 2012 Pharma Company Updates Indicate Upcoming Catalysts at Seeking Alpha +7.50%
20-Nov-12 04:15PM  InPlay: Acura Pharma announces successful bioequivalent study for NEX Briefing.com -6.78%
04:15PM  Acura Pharmaceuticals Announces Successful Bioequivalent Study for NEXAFED Marketwire
16-Nov-12 01:04PM  ACURA PHARMACEUTICALS, INC Financials EDGAR Online Financials +5.36%
07-Nov-12 10:29AM  Acura Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
06-Nov-12 04:22PM  ACURA PHARMACEUTICALS, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies. Its products include Oxecta Tablets CII, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed, an over-the-counter immediate-release pseudoephedrine HCl tablet that is used as a nasal decongestant in various non-prescription and prescription cold, sinus, and allergy products. The company has seven additional opioid products utilizing Aversion technology in various stages of development. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc., a wholly-owned subsidiary of Pfizer Inc. to develop and commercialize certain opioid analgesic products utilizing the company's proprietary Aversion technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARE CAPITAL II LLC10% OwnerMay 23Sale2.3262,000143,8405,828,815May 23 05:45 PM
CARE CAPITAL II LLC10% OwnerMay 22Sale2.3095,000218,5005,890,815May 23 05:45 PM
SKELLY WILLIAM GDirectorMay 22Sale2.334,0009,32029,000May 23 02:31 PM
CARE CAPITAL II LLC10% OwnerMay 21Sale2.3195,000219,4505,985,815May 23 05:45 PM
CLAUDIUS LLC10% OwnerMay 21Sale2.3047,410108,97711,877,035May 23 05:18 PM
CARE CAPITAL II LLC10% OwnerMay 20Sale2.39160,000382,4006,080,815May 21 04:27 PM
CLAUDIUS LLC10% OwnerMay 20Sale2.3968,993165,23111,924,445May 20 06:20 PM
CARE CAPITAL II LLC10% OwnerMay 17Sale2.35350,000822,5006,240,815May 21 04:27 PM
CLAUDIUS LLC10% OwnerMay 17Sale2.3654,460128,29111,993,438May 20 06:20 PM
SKELLY WILLIAM GDirectorMay 16Sale2.253,0006,75033,000May 20 11:48 AM
CLAUDIUS LLC10% OwnerMay 16Sale2.2142,59994,09312,047,898May 20 06:20 PM
CARE CAPITAL II LLC10% OwnerMay 16Sale2.2050,000110,0006,590,815May 16 05:29 PM
CARE CAPITAL II LLC10% OwnerMay 15Sale2.2762,000140,7406,640,815May 16 05:29 PM
CLAUDIUS LLC10% OwnerMay 15Sale2.2723,58553,60612,090,497May 15 05:36 PM
CARE CAPITAL II LLC10% OwnerMay 14Sale2.41550,0001,325,5006,702,815May 16 05:29 PM
CLAUDIUS LLC10% OwnerMay 14Sale2.4487,399213,22712,114,082May 15 05:36 PM
CARE CAPITAL II LLC10% OwnerMay 13Sale2.22135,000299,7007,252,815May 13 05:48 PM
CLAUDIUS LLC10% OwnerMay 13Sale2.2172,450160,05712,201,481May 15 05:36 PM
CARE CAPITAL II LLC10% OwnerMay 10Sale2.1662,000133,9207,387,815May 13 05:48 PM
CARE CAPITAL II LLC10% OwnerMay 09Sale2.1762,000134,5407,449,815May 13 05:48 PM
SKELLY WILLIAM GDirectorMay 09Sale2.203,0006,60036,000May 13 09:50 AM
CARE CAPITAL II LLC10% OwnerMay 08Sale2.1562,000133,3007,511,815May 08 05:58 PM
CLAUDIUS LLC10% OwnerMay 07Sale2.2320,88746,65112,334,527May 07 06:45 PM
CARE CAPITAL II LLC10% OwnerMay 07Sale2.1962,000135,7807,573,815May 07 06:42 PM
CLAUDIUS LLC10% OwnerMay 06Sale2.12105,300223,59412,355,414May 07 06:45 PM
EMIGH JAMES FVP Corporate DevelopmentMay 03Option Exercise1.306,2258,093177,079May 06 12:45 PM
CLAUDIUS LLC10% OwnerMay 03Sale2.2627,11761,24912,460,714May 07 06:45 PM
CARE CAPITAL II LLC10% OwnerMay 03Sale2.2783,252188,9827,635,815May 07 06:42 PM
CARE CAPITAL II LLC10% OwnerMay 02Sale2.4795,000234,6507,719,067May 03 04:15 PM
CLAUDIUS LLC10% OwnerMay 02Sale2.4749,937123,34412,487,831May 02 05:51 PM
CARE CAPITAL II LLC10% OwnerMay 01Sale2.4095,000228,0007,814,067May 03 04:15 PM
CLAUDIUS LLC10% OwnerMay 01Sale2.37106,027251,69712,537,768May 02 05:51 PM
CLAUDIUS LLC10% OwnerApr 30Sale2.4818,79446,57712,643,795May 02 05:51 PM
CLAUDIUS LLC10% OwnerApr 29Sale2.5613,64234,89912,662,589Apr 29 05:28 PM
CLAUDIUS LLC10% OwnerApr 26Sale2.5526,00066,42212,676,231Apr 29 05:28 PM
CLAUDIUS LLC10% OwnerApr 25Sale2.6716,70044,54912,702,231Apr 29 05:28 PM
CARE CAPITAL II LLC10% OwnerApr 25Sale2.68100,000268,0008,260,067Apr 26 04:37 PM
CARE CAPITAL II LLC10% OwnerApr 24Sale2.5882,000211,5608,360,067Apr 26 04:37 PM
CARE CAPITAL II LLC10% OwnerApr 23Sale2.67315,000841,0508,442,067Apr 24 04:57 PM
CARE CAPITAL II LLC10% OwnerApr 22Sale3.02500,0001,510,0008,757,067Apr 24 04:57 PM
CARE CAPITAL II LLC10% OwnerApr 17Sale3.33321,6821,071,2019,257,067Apr 19 05:47 PM
CLAUDIUS LLC10% OwnerApr 17Sale3.20238,756765,09412,718,931Apr 19 04:39 PM
CLAUDIUS LLC10% OwnerApr 16Sale2.1121,80045,93512,957,687Apr 16 06:56 PM
CLAUDIUS LLC10% OwnerApr 15Sale2.104,3039,02212,979,487Apr 16 06:56 PM
CLAUDIUS LLC10% OwnerApr 12Sale2.2213,20029,32212,983,790Apr 16 06:56 PM
CLAUDIUS LLC10% OwnerApr 11Sale2.2496,336216,00512,996,990Apr 11 06:39 PM
CLAUDIUS LLC10% OwnerApr 10Sale2.1625,11854,37513,093,326Apr 11 06:39 PM
CLAUDIUS LLC10% OwnerApr 09Sale2.1420,00042,80013,118,444Apr 09 06:56 PM
CLAUDIUS LLC10% OwnerApr 08Sale2.1680,554173,80313,138,444Apr 09 06:56 PM
CLAUDIUS LLC10% OwnerApr 05Sale2.1699,933215,54513,218,998Apr 09 06:56 PM
SKELLY WILLIAM GDirectorApr 03Sale2.056,00012,27039,000Apr 04 11:44 AM
CARE CAPITAL II LLC10% OwnerApr 02Sale2.157,41615,9449,578,749Apr 04 05:46 PM
CARE CAPITAL II LLC10% OwnerMar 28Sale2.2010,00022,0009,586,165Apr 01 04:55 PM
CARE CAPITAL II LLC10% OwnerMar 26Sale2.1527,00058,0509,596,165Mar 26 06:07 PM
CARE CAPITAL II LLC10% OwnerMar 22Sale2.2112,55427,7449,623,165Mar 26 06:07 PM
CARE CAPITAL II LLC10% OwnerMar 21Sale2.2486,000192,6409,635,719Mar 22 05:04 PM
CARE CAPITAL II LLC10% OwnerMar 20Sale2.3417,21540,2839,721,719Mar 22 05:04 PM
CARE CAPITAL II LLC10% OwnerMar 18Sale2.3631,37574,0459,738,934Mar 20 05:05 PM
CARE CAPITAL II LLC10% OwnerMar 15Sale2.3759,410140,8029,770,309Mar 18 04:45 PM
CARE CAPITAL II LLC10% OwnerMar 14Sale2.5259,000148,6809,829,719Mar 18 04:45 PM
CARE CAPITAL II LLC10% OwnerMar 13Sale2.5029,00072,5009,888,719Mar 14 05:47 PM
CARE CAPITAL II LLC10% OwnerMar 12Sale2.4844,000109,1209,917,719Mar 14 05:47 PM
SKELLY WILLIAM GDirectorMar 07Sale2.525,00012,60045,000Mar 07 04:03 PM
Seiser Robert AVP, Controller & TreasurerMar 05Option Exercise1.306,2258,093137,522Mar 06 03:28 PM
SKELLY WILLIAM GDirectorNov 27Sale1.255,3416,67650,000Nov 28 05:24 PM
SKELLY WILLIAM GDirectorNov 15Sale1.154,6595,35855,341Nov 16 11:23 AM
SKELLY WILLIAM GDirectorNov 09Sale1.285,0006,40060,000Nov 13 12:04 PM
open in yahoo | open in reuters | open in google